Loading
A phase 3 trial of Carboplatin and Ethiodized oil in Hepatocellular carcinoma, run by Sun Yat-sen University, with a status the registry has not verified recently.
Liver Resection Versus Transarterial Chemoembolization for the Treatment of Intermediate-stage Hepatocellular Carcinoma is a phase 3 interventional study registered as NCT02755311 by Sun Yat-sen University, with 198 participants planned, started 2014-03 and due to reach its primary completion in 2016-06. Interventions recorded: liver resection, transarterial chemoembolization, carboplatin, lipiodol, epirubicin, pirarubicin, hydroxycamptothecin and fluorouracil, absorbable gelatin sponge particles. Conditions recorded: Hepatocellular Carcinoma.
Linked to the drug Ethiodized oil because the registry names it among its interventions and Hepatocellular carcinoma among its conditions. Registry record only: no result has been read by an editor.
Shares Ethiodized oil, Intermediate hepatocellular carcinoma (BCLC B), Hepatocellular carcinoma and the tag pipeline.
Shares Ethiodized oil, Intermediate hepatocellular carcinoma (BCLC B), Hepatocellular carcinoma and the tag pipeline.
Shares Intermediate hepatocellular carcinoma (BCLC B), Hepatocellular carcinoma and the tag pipeline.
Shares Intermediate hepatocellular carcinoma (BCLC B), Hepatocellular carcinoma and the tag pipeline.
Shares Intermediate hepatocellular carcinoma (BCLC B), Hepatocellular carcinoma and the tag pipeline.
Shares Intermediate hepatocellular carcinoma (BCLC B), Hepatocellular carcinoma and the tag pipeline.
Shares Hepatocellular carcinoma and the tag pipeline.
Shares Hepatocellular carcinoma and the tag pipeline.